The five-factor score revisited: Assessment of prognoses of systemic necrotizing vasculitides based on the french vasculitis study group (FVSG) cohort

Medicine

Volumn 90, Issue 1, 2011, Pages 19-27

  Guillevin, Loïc ^a,b   Pagnoux, Christian ^a,b   Seror, Raphaele ^a   Mahr, Alfred ^a   Mouthon, Luc ^a,b   Toumelin, Philippe Le ^c  

^a National Referral Center for Rare Systemic and Autoimmune Diseases: Vasculitides and Scleroderma   (United States)

^b université Paris Cité   (France)

^c UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ABSENCE; ACUTE KIDNEY FAILURE; ADULT; AGE; APPENDICITIS; ARTICLE; CHOLECYSTITIS; CHURG STRAUSS SYNDROME; CLINICAL ASSESSMENT TOOL; CLINICAL LABORATORY; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA BASE; DEATH; EAR; FEMALE; FRANCE; HEART DISEASE; HEART FAILURE; HEMATURIA; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MORTALITY; NOMENCLATURE; NOSE; ORGAN WEIGHT; OTORHINOLARYNGOLOGY; OUTCOME ASSESSMENT; PANCREATITIS; PHENOTYPE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RHEUMATOLOGY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; THROAT; VISCERA; WEGENER GRANULOMATOSIS;

BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHURG-STRAUSS SYNDROME; FEMALE; FRANCE; HUMANS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; POLYARTERITIS NODOSA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 78651242903     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e318205a4c6     Document Type: Article

References (36)

1. Bligny D, Mahr A, Toumelin PL, Mouthon L, Guillevin L. Predicting mortality in systemic Wegeners granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum. 2004;51:83-91.
2. Charlier C, Henegar C, Launay O, Pagnoux C, Berezné A, Bienvenu B, Cohen P, Mouthon L, Guillevin L. Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis. 2009;68:658-663.
3. Cohen P, Pagnoux C, Mahr A, Arène JP, Mouthon L, Le Guern V, André MH, Gayraud M, Jayne D, Blöckmans D, Cordier JF, Guillevin L. Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum. 2007;57:686-693.
4. Cox D. Regression models and life tables. J R Stat Soc. 1972;34:187-219.
5. de Groot K, Gross WL, Herlyn K, Reinhold-Keller E. Development and validation of a disease extent index for Wegeners granulomatosis. Clin Nephrol. 2001;55:31-38.
6. de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med. 2009;150:670-680.
7. Exley AR, Bacon PA. Clinical disease activity in systemic vasculitis. Curr Opin Rheumatol. 1996;8:12-18.
8. Gayraud M, Guillevin L, Le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001;44:666-675.
9. Guillevin L, Cohen P, Mahr A, Arène JP, Mouthon L, Puéchal X, Pertuiset E, Gilson B, Hamidou M, Lanoux P, Bruet A, Ruivard M, Vanhille P, Cordier JF. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum. 2003;49:93-100.
10. Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson JF, Detree F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegeners granulomatosis. Arthritis Rheum. 1997;40:2187-2198.
11. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). 1996;75:17-28.
12. Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P; French Vasculitis Study Group. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore). 2005;84:313-322.
13. Haworth SJ, Savage CO, Carr D, Hughes JM, Rees AJ. Pulmonary haemorrhage complicating Wegeners granulomatosis and microscopic polyarteritis. Br Med J (Clin Res Ed). 1985;290:1775-1778.
14. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7:23-32.
15. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36-44. (Pubitemid 36765101)
16. Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, Westman KW, Van Der Woude FJ, de Lind Van Wijngaarden RA, Pusey CD. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18:2180-2188.
17. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, HunDer GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-192.
18. Jennings CA, King TE Jr, TuDer R, Cherniack RM, Schwarz MI. Diffuse alveolar hemorrhage with unDerlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med. 1997;155:1101-1109.
19. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
20. Khan SA, Subla MR, Behl D, Specks U, Afessa B. Outcome of patients with small-vessel vasculitis admitted to a medical ICU. Chest. 2007;131:972-976.
21. Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis. 2003;42:1149-1153.
22. Lamprecht P, Erdmann A, Mueller A, Csernok E, Reinhold-Keller E, Holl-Ulrich K, Feller AC, Bruehl H, Gross WL. Heterogeneity of CD4 and CD8+ memory T cells in localized and generalized Wegeners granulomatosis. Arthritis Res Ther. 2003;5:R25-R31.
23. Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, Cordier JF. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe dEtudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore). 2000;79:222-233.
24. Leavitt RY, Fauci AS, Bloch DA, Michel BA, HunDer GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr, et al. The American College of Rheumatology 1990 criteria for the classification of Wegeners granulomatosis. Arthritis Rheum. 1990;33:1101-1107.
25. Lightfoot RW Jr, Michel BA, Bloch DA, HunDer GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088-1093.
26. Luqmani RA, Bacon PA, Beaman M, Scott DG, Emery P, Lee SJ, Howie AJ, Richards N, Michael J, Adu D. Classical versus non-renal Wegeners granulomatosis. Q J Med. 1994;87:161-167.
27. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87:671-678.
28. Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegeners granulomatosis and prospective follow-up. Rheumatology (Oxford). 2001;40:492-498.
29. Masi AT, HunDer GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094-1100.
30. Merkel PA, Seo P, Aries P, Neogi T, Villa-Forte A, Boers M, Cuthbertson D, Felson DT, Hellmich B, Hoffman GS, Jayne DR, Kallenberg CG, Krischer J, Mahr A, Matteson EL, Specks U, Luqmani R, Stone J. Current status of outcome measures in vasculitis: focus on Wegeners granulomatosis and microscopic polyangiitis. Report from OMERACT 7. J Rheumatol. 2005;32: 2488-2495.
31. Mouthon L, Le Toumelin P, André MH, Gayraud M, Casassus P, Guillevin L. Polyarteritis nodosa and Churg-Strauss angiitis: characteristics and outcome in 38 patients over 65 years. Medicine (Baltimore). 2002;81:27-40.
32. Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis. 2008;67:1004-1010.
33. Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puechal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008;359: 2790-2803.
34. Ribi C, Cohen P, Pagnoux C, Mahr A, Arène J, Puéchal X, Carli P, Kyndt X, Le Hello C, Letellier P, Cordier J, Guillevin L; French Vasculitis Study Group. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients. Arthritis Rheum. 2010;62:1186-1197.
35. Ribi C, Cohen P, Pagnoux C, Mahr A, Arène JP, Lauque D, Puéchal X, Letellier P, Delaval P, Cordier JF, Guillevin L. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum. 2008;58:586-594.
36. Stone JH, Hoffman GS, Merkel PA, Min YI, UhlfelDer ML, Hellmann DB, Specks U, Allen NB, Davis JC, Spiera RF, Calabrese LH, Wigley FM, Maiden N, Valente RM, Niles JL, Fye KH, McCune JW, St Clair EW, Luqmani RA. A disease-specific activity index for Wegeners granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum. 2001;44:912-920.